December 2020

Sir John Bell joins Hakluyt International Advisory Board

Hakluyt is proud to announce that Sir John Bell, Regius Professor of Medicine at the University of Oxford, has joined the company’s advisory board.

The Hakluyt International Advisory Board provides the company with advice and connectivity across the globe. It is chaired by Niall FitzGerald KBE, former CEO and chairman of Unilever, and members are drawn from the worlds of business, government and academia.

Professor Sir John Bell brings to Hakluyt more than 40 years of distinguished experience in medicine in North America and Europe. His research has focused on auto-immune disease and immunology, and he has worked with universities, businesses, governments and other organisations on a wide range of medical and scientific issues.

Varun Chandra, Hakluyt’s managing partner, said: “I am delighted that Professor Sir John Bell will be joining the Hakluyt International Advisory Board. The past year has, of course, reminded everyone just how important developments in science and medicine can be for decision-makers in all walks of life, including business. As we help corporate leaders and investors around the world make better decisions, we are honoured that Sir John has chosen to join the Hakluyt team.”

Niall FitzGerald KBE added: “It is a pleasure to welcome Sir John Bell to the Hakluyt International Advisory Board. Having chaired this fascinating group for several years, I know he will bring a great deal of expertise and insight to our discussions about the issues facing business leaders. I am very much looking forward to working with him.”

Sir John Bell commented: “I am very pleased to be joining the Hakluyt International Advisory Board. I have long believed in the importance of business and science working together to manage risks and create opportunities. At the end of 2020, this feels more relevant than ever before. I am sure I will enjoy working with Hakluyt and the other members of the company’s advisory board.”

Sir John Bell’s appointment to the Hakluyt International Advisory Board is effective immediately.

BACK
BACK